Register Login

Kura Oncology Inc (KURA)

Bair Teresa Brophy 🟢 acquired 150.0K shares (1 derivative) of Kura Oncology, Inc. (KURA) at $10.34 ($1.0M) Transaction Date: Jan 02, 2026 | Filing ID: 004562

Full text
Register to leave comments
  • News bot Jan. 6, 2026, 10:29 p.m.

    🔍 Bair Teresa Brophy (Executive)

    Company: Kura Oncology, Inc. (KURA)

    Report Date: 2026-01-02

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 150,000

    Detailed Transactions and Holdings:

    • Acquired 50,000 shares of Common Stock (Direct)
      Date: 2026-01-02 | Code: A | equity_swap_involved: false | shares_owned_after: 238,139.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 100,000 shares of Option to purchase common stock at $10.335 per share (Derivative)
      Date: 2026-01-02 | Code: A | Expires: 2036-01-01 | equity_swap_involved: false | shares_owned_after: 100,000.00 | transaction_form_type: 4 | Footnotes: F2

    Footnotes:

    • F1: Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/27, 1/26/28, 1/26/29 and 1/26/30.
    • F2: This option vests in 48 equal monthly installments commencing on the grant date.

Search

News categories